Correlation Between Israel China and Infimer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Israel China and Infimer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel China and Infimer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Israel China Biotechnology and Infimer, you can compare the effects of market volatilities on Israel China and Infimer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel China with a short position of Infimer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel China and Infimer.

Diversification Opportunities for Israel China and Infimer

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Israel and Infimer is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Israel China Biotechnology and Infimer in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Infimer and Israel China is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel China Biotechnology are associated (or correlated) with Infimer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Infimer has no effect on the direction of Israel China i.e., Israel China and Infimer go up and down completely randomly.

Pair Corralation between Israel China and Infimer

Assuming the 90 days trading horizon Israel China is expected to generate 77.82 times less return on investment than Infimer. But when comparing it to its historical volatility, Israel China Biotechnology is 10.77 times less risky than Infimer. It trades about 0.02 of its potential returns per unit of risk. Infimer is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  7,400  in Infimer on August 27, 2024 and sell it today you would lose (7,260) from holding Infimer or give up 98.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Israel China Biotechnology  vs.  Infimer

 Performance 
       Timeline  
Israel China Biotech 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Israel China Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong fundamental drivers, Israel China is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Infimer 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Infimer are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Infimer sustained solid returns over the last few months and may actually be approaching a breakup point.

Israel China and Infimer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Israel China and Infimer

The main advantage of trading using opposite Israel China and Infimer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel China position performs unexpectedly, Infimer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Infimer will offset losses from the drop in Infimer's long position.
The idea behind Israel China Biotechnology and Infimer pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stocks Directory
Find actively traded stocks across global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA